Related Experiment Videos
αCGRP Affects BMSCs' Migration and Osteogenesis via the Hippo-YAP Pathway
Bin Wang1,2,3, Jie Lin2,3, Qin Zhang1,2
1State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Cell Transplantation
|August 21, 2019
Summary
Alpha-calcitonin gene-related peptide (αCGRP) enhances bone regeneration by boosting mesenchymal stem cell migration and osteogenic differentiation. This peptide promotes bone healing by activating YAP signaling, offering a novel therapeutic approach.
Area of Science:
- Molecular Biology
- Cell Biology
- Regenerative Medicine
Background:
- Alpha-calcitonin gene-related peptide (αCGRP) is implicated in bone metabolism regulation.
- Previous in vivo studies suggest αCGRP may enhance osseointegration.
- Understanding αCGRP's mechanism in bone regeneration requires further investigation.
Purpose of the Study:
- To investigate the impact of αCGRP on osteogenic differentiation in bone marrow-derived mesenchymal stem cells (BMSCs).
- To elucidate the intrinsic molecular mechanisms underlying αCGRP's role in bone regeneration.
- To explore the potential of αCGRP as a therapeutic agent for bone healing.
Main Methods:
- Utilized αCGRP lentivirus for stable transfection into BMSCs from wild-type and αCGRP knockout mice.
- Performed transfection identification and cell cycle assays.
- Conducted in vitro functional assays to assess migratory ability and osteogenicity.
Main Results:
- Increased αCGRP expression in BMSCs positively correlated with enhanced migratory ability and osteogenicity.
- This effect was associated with upregulated expression of YAP (Yes-associated protein), a key Hippo pathway effector.
- αCGRP deficiency in BMSCs impaired these crucial bone regeneration functions.
Conclusions:
- αCGRP significantly promotes osteogenic differentiation and migration in BMSCs.
- The mechanism involves the activation of the YAP signaling pathway.
- αCGRP represents a promising therapeutic target for promoting bone wound healing and regeneration.